Australian medtech body calls for purchasing enquiry:
This article was originally published in Clinica
The Medical Industry Association of Australia is calling for an urgent enquiry into Commonwealth and State purchasing of medical products. The body is about to submit a report to the Industry Commission enquiry which is examining ways to enhance the development prospects of the medtech industry in Australia. The MIAA believes the enquiry must take full account of those companies not engaged in local manufacture. MIAA chairman Rob Gregg also called on industry to submit comments on the Commission's draft paper, which will be released in mid-July for public comment. The government deadline for the final report is February 24th, 1997.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.